Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 September 2020 | Story Leonie Bolleurs | Photo Supplied
With the research grant awarded to Dr Thulisile Mphambukeli, she has the opportunity to make a difference in society, especially in terms of the incorporation of social justice into planning.

The Joint National Institute for the Humanities and Social Sciences (NIHSS) and Chinese Academy of Social Sciences (CASS) research projects have awarded a R500 000 research grant to a team led by Dr Thulisile Mphambukeli, the principal investigator (PI). 

Within the parameters of the theme of social justice, sustainable development, and quality of life, Dr Mphambukeli’s team will focus their research on exploring the land policies in BRICS that inform agricultural practices. They will also document the policy approaches and strategies adopted by China and South Africa respectively to support the agriculture-land-water-labour nexus; additionally, they will propose a common agricultural land policy for China and South Africa. 

The title of the research project is: Exploring the Situated Political Ecology and Economy of Agricultural Land Policies in BRICS: A Case Study of China and South Africa. 

Dr Mphambukeli, who is passionate about social justice, is a Senior Lecturer in the Department of Urban and Regional Planning at the University of the Free State (UFS). With this project, she has the opportunity to make a difference in society, especially in terms of social justice. 

 

We don’t want to see the next generation suffer because we did not use our voice.- Dr Thulisile Mphambukeli

The human factor is crucial

“We need to understand the dynamics of local communities. The incorporation of social justice in planning is crucial! We cannot claim that we ‘plan for people’ and ignore them at the same time. People must be at the centre of what we do. No one must be deprived of their fundamental basic human rights.”

The team consists of Dr Mphambukeli (PI), Prof Peliwe Lolwana (University of the Witwatersrand), Dr Victor Okorie (Enugu State University of Science and Technology, Nigeria), and Dr Abraham Matamanda (UFS).

For this initiative, the China Africa Institute (CAI), which is part of CASS, joined hands with the NIHSS. Together, they will oversee the research projects of researchers and academics from South Africa and China. The research project, running from 1 April this year to 31 March 2021, will bring forth publications/research outputs, advocacy policy briefs, and proceeding reports.

The programme aims to strengthen research in the field of the humanities and social sciences between the two countries. 

Support the fight against climate change

She believes that although the BRICS countries are not geographically connected, it is a functional community with the same interests. “As BRICS countries, we need to cooperate in the fight against climate change. It affects so many components, including water, food, agriculture, land, and quality of infrastructure,” says Dr Mphambukeli. 

Due to the current COVID-19 pandemic, researchers will meet online to discuss how China and South Africa can collaborate and cooperate. “We don’t want to see the next generation suffer because we did not use our voice,” she says. 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept